EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Hereditary Alpha-Tryptasemia (HαT) as a Risk Modifier for Severe Anaphylaxis

Abigail Lang, Wajiha Kazmi, Jonathan J Lyons

Immunology and Allergy Clinics of North America · 2026-05 · 46 (2) · 373-383

DOI: 10.1016/j.iac.2026.01.010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunology and Allergy Clinics of North America, 2026-05. Verfasst von Abigail Lang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Immunology, Ann and Robert H. Lurie Children's Hospital of Chicago, Department of Pediatrics at Northwestern University Feinb…. Hauptthemen laut MEDLINE: Anaphylaxis, Tryptases. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Biogen, NIAID.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hereditary alpha-tryptasemia (HαT) is a common autosomal dominant genetic trait that results from increased copy numbers of the TPSAB1 gene encoding α-tryptase. Studies have shown that increased relative α-tryptase expression can modify mast-cell-mediated reactions and contribute to increased severity of anaphylaxis. HαT is an independent risk modifier for reaction severity in patients with Hymenoptera venom allergy and systemic mastocytosis. Additionally, there is emerging evidence that HαT and α-tryptase expression more generally are also associated with increased risk of severe reactions to other allergens. Tryptase genotyping may be a promising biomarker for risk stratification of IgE-mediated allergic reaction severity in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnaphylaxisTryptasesHumansAnimalsGenetic Predisposition to DiseaseVenom HypersensitivityImmunoglobulin EMast CellsRisk FactorsAllergensSeverity of Illness IndexMast Cell Activation Syndrome

Stichwörter der Autor:innen

AnaphylaxisDrug allergyFood allergyHereditary alpha-tryptasemiaMastocytosis

Substanzen

TryptasesTPSAB1 protein, humanImmunoglobulin EAllergens

Autor:innen und Institutionen

  • Division of Allergy and Immunology, Ann and Robert H. Lurie Children's Hospital of Chicago, Department of Pediatrics at Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Department of Internal Medicine, Zucker School of Medicine, Hofstra/Northwell, Hempstead, NY, USA.
  • Division of Allergy & Immunology, Department of Medicine, University of California San Diego, La Jolla, CA, USA; Veterans Affairs San Diego Healthcare System, La Jolla, CA, USA. Electronic address: j3lyons@health.ucsd.e…

Förderung

  • NIAID NIH HHS
  • Biogen
  • NIAID

Zitieren

APA

Lang, A., Kazmi, W., & Lyons, J. J. (2026). Hereditary Alpha-Tryptasemia (HαT) as a Risk Modifier for Severe Anaphylaxis. Immunology and Allergy Clinics of North America, 46(2), 373-383. https://doi.org/10.1016/j.iac.2026.01.010

Vancouver

Lang A, Kazmi W, Lyons JJ. Hereditary Alpha-Tryptasemia (HαT) as a Risk Modifier for Severe Anaphylaxis. Immunology and Allergy Clinics of North America. 2026;46(2):373-383. doi:10.1016/j.iac.2026.01.010

BibTeX
@article{Lang2026,
  author = {Lang, Abigail and Kazmi, Wajiha and Lyons, Jonathan J},
  title = {Hereditary Alpha-Tryptasemia (HαT) as a Risk Modifier for Severe Anaphylaxis},
  journal = {Immunology and Allergy Clinics of North America},
  year = {2026},
  volume = {46},
  number = {2},
  pages = {373--383},
  doi = {10.1016/j.iac.2026.01.010}
}
Kostenlos starten →